← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1997First marketed drug
Jan 1, 1981First NDA
Nov 2, 1998Last known activity
Nov 1, 2009
Acquired by Amgen on Jan 1, 2002
Timeline
1950s
- Mar 9, 1959
thiotepa— NDA Secondary Org
1980s
- Jan 1, 1981
Immunex— Founded
1990s
- Nov 2, 1998
etanercept— Marketing Organization
- Nov 2, 1998
etanercept— NDA Organization
2000s
- Jan 1, 2002
Amgen— Acquired By
Drugs by trial phase (15 distinct, 19 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (3)
Recent trials (19)
- NCT01001208CollaboratorPhase 3Nov 1, 2009
- NCT00346294CollaboratorPhase 4Jan 31, 2006
- NCT00249041CollaboratorPhase 3Oct 1, 2005
- NCT00061126CollaboratorPhase 2Apr 1, 2003
- NCT00111436CollaboratorPhase 3Apr 1, 2003
- NCT00035958CollaboratorPhase 2/Phase 3Aug 1, 2002
- NCT00205231CollaboratorN/AMay 1, 2002
- NCT00356356CollaboratorPhase 3Apr 1, 2002
- NCT00201838CollaboratorPhase 1/Phase 2Jul 1, 2001
- NCT00078806CollaboratorPhase 3Jun 1, 2001
- NCT00038870CollaboratorN/AJan 1, 2001
- NCT00201812CollaboratorPhase 1Nov 1, 2000
- NCT00317499CollaboratorPhase 3Apr 1, 2000
- NCT00132418CollaboratorPhase 4Apr 1, 2000
- NCT00145639CollaboratorPhase 2May 1, 1999
Details
- Founded
- Seattle, WA, US Jan 1, 1981
- First NDA
- Nov 2, 1998
- Last known activity
- Nov 1, 2009
Designations held
- Orphan drug
Notes
Acquired by Amgen